N14.2

Clinical Causes: Use of medications known to have nephrotoxic effects, such as certain antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), or chemotherapy agents. Long-term or high-dose use of specific drugs that can harm kidney tissue. Reactions to biological substances like vaccines or other immune-modulating therapies that lead to kidney inflammation. Unintended drug interactions increasing the risk of kidney damage. Pre-existing kidney conditions exacerbated by drug therapy.

Key Symptoms: Reduced urine output or changes in urine appearance. Swelling in the legs, ankles, or around the eyes due to fluid retention. Fatigue and weakness from reduced kidney function. High blood pressure that may be difficult to control. Nausea or vomiting. Confusion or difficulty concentrating in advanced stages. Dark-colored urine or presence of blood in urine.

Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, and laboratory tests. Blood tests, such as serum creatinine and blood urea nitrogen (BUN), assess kidney function. Urinalysis can reveal protein, blood, or other abnormalities indicating kidney damage. Imaging studies, like ultrasounds, help evaluate kidney structure. In some cases, a kidney biopsy may be necessary to confirm the diagnosis and determine the extent of damage.

Treatment Protocols: Managing drug-induced nephropathy involves discontinuing or adjusting the offending medication under medical supervision. Supportive treatments may include controlling blood pressure, reducing protein intake, and managing fluid balance. In cases of significant kidney impairment, dialysis or other renal replacement therapies might be needed. Ongoing monitoring of kidney function is essential to prevent further damage and adapt treatment plans accordingly.